AzTrials
AzTrials

Hepatitis C and B VIRUS Screening, Awareness and Behavior Assessment and Evaluation for All Inhabitants Above Twelve Years of Al Othmaneya VillageNCT03415334

Effect of Implementation Of Outreach Behavioral Change Program for HCV Elimination

A study testing behavioral development for change in people with Hepatitis C and B VIRUS Screening, Awareness and Behavior Assessment and Evaluation for All Inhabitants Above Twelve Years of Al Othmaneya Village, run by National Research Centre, Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Elimination of hepatitis C virus (HCV) is the process of stopping sustained transmission of viral hepatitis, reducing its incidence to zero and providing access to safe, affordable and effective treatment and care for everyone. Consequently, HCV will not be a leading cause of mortality (1). Read more about this study

Who is it for?
Ages 12 years and olderHealthy volunteers can take part
What is being tested?
behavioral development for change
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3,575 participants
Where
No sites listed yet
Study dates
21 May 2015to 21 Oct 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • All village inhabitants starting from 12 years old

Who cannot join

  • inhabitants less than 12 years old

About this study

Official title: Use of Public Health Approaches for HCV Elimination in an Egyptian Model Village

Elimination of hepatitis C virus (HCV) is the process of stopping sustained transmission of viral hepatitis, reducing its incidence to zero and providing access to safe, affordable and effective treatment and care for everyone. Consequently, HCV will not be a leading cause of mortality (1). The World Health Organization (WHO) called for comprehensive programs that enhance access to affordable treatment in developing countries as HCV was considered a global public health priority since 2010 and set criteria of elimination(2). A disease is eliminated if its controlling efforts are sufficient to prevent an epidemic from occurring in a given geographical area and measures must be continued to prevent re-establishment of transmission (3) According to the Centers for Disease Control and Prevention (CDC), HCV now surpasses HIV as the nation's deadliest blood-borne disease. In addition, the majority of infected persons are not aware of their infection as they are not clinically ill and there is no vaccine for Hepatitis C. It is well known that the best way to prevent Hepatitis C is by avoiding behaviors that can spread the disease. (4) This study is a way forward for the elimination of hepatitis C from Egypt through applying different public health approaches for motivating people and changing villagers' risky behaviors aiming at increasing the number of people adopting healthy practices for decreasing the incidence rate of hepatitis in El Othmaneya village. The proposed activities along one year were applied for 3575 inhabitants aged more than 12 years who were get tested for Hepatitis C Virus (HCV) antibodies. The initiative activities were provided by community-led coalition and supported technically by the Egyptian Liver Research Institute and Hospital (ELRIAH).

Read the detailed description

The objective of the outreach village initiative is to capture in more detail the dominance of the risky behaviors as well as the level of behavior development and putting adaptive motivational strategies aiming at behavior change. In addition, the initiative set public health approaches for HCV elimination and evaluate its efficacy in changing behaviors.

Methodology The initiative was interventional evaluation study which was conducted along 24 months starting from May 2015 to October 2017.

Phases of the study:

The study passed through three phases; first phase pre-interventional assessment of level of the recommended behavior development towards eradication of HCV, dominance of current risky behaviors and the wrong believes regarding HCV . The second phase included: community based interventions and the setting of the educational activation plan for HCV elimination in the village and the third was post-intervention evaluation of the change of level of community behaviors adoption according to a preset indicators.

Indicators are the following:

Awareness:

  1. Using previously used syringes
  2. Sharing shaving equipment, nail cutters or through needle stick injury
  3. Defect in infection control process during sessions for teeth treatment
  4. sharing tooth brush with other family members
  5. It is better for HCV patients to get vaccinated with Hepatitis B vaccines
  6. Using new syringes/sharp instruments which are not used before could reduce the risk of becoming infected with HCV
  7. Awareness by the recommended behaviors can limit the complication and propagation of HCV infection

Perception:

  1. HCV is a serious disease
  2. Hepatocellular carcinoma (HCC) is a complication of HCV
  3. Cirrhosis is a complication of HCV
  4. Early diagnosis could make a change in patients' health
  5. Fatigue from least effort is symptom of HCV

The Attitude:

  1. Asking the barber: to change the shaving tools in front of them
  2. to use their own shaving machine
  3. Checking for sterilized tools at dentist clinic
  4. Telling the dentist if they have/ had HCV

The tried out / rejected or adopted : Not sharing:

  1. nail cutters and scissors between family members
  2. loofah and sponge for personal cleaning
  3. the use of scarves' pins by the veiled females in the same family
  4. other's shaving tools
  5. others tooth brushes
Being tested
behavioral development for change
Keywords
Hepatitis C, social marketing, Communication for behavior development
Medical subject headings
Hepatitis C

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • behavioral development for changeBehavioural

    Also called 2 approaches were used : 1) Social Marketing Principles (4Ps) 2) Communication for Behavior Development Approach

    1. Social Marketing Principles (4 Ps) Product, price, place and promotion
    2. Communication for Behavior Development Approach 1. Interpersonal communication campaigns (IPC) 2. Mass media and public gathering awareness campaigns 3. Public health awareness campaigns 4. A village hotline and local satellite channel 5. School awareness raising events
Study groups in NCT03415334
Study groupRoleWhat they receive
behavioral changeOthertwo approaches for behavior changes : social marketing and behavioral development
Receives: Behavioral: behavioral development for change

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. percent change of awareness using pre and post intervention questionnaire for participants who became aware of the problem

    1. Using previously used syringes
    2. Sharing shaving equipment, nail cutters or through needle stick injury
    3. Defect in infection control process during sessions for teeth treatment
    4. sharing tooth brush with other family members
    5. It is better for HCV patients to get vaccinated with Hepatitis B vaccines
    6. Using new syringes/sharp instruments which are not used before could reduce the risk of becoming infected with HCV
    7. Awareness by the recommended behaviors can limit the complication and propagation of HCV infection

    Measured: two years

  2. Percent change using pre and post intervention questionnaire for participants who became concerned about the problem,acquired knowledge and internalized the knowledge

    Perception:

    1. HCV is a serious disease
    2. HCC is a complication of HCV
    3. Cirrhosis is a complication of HCV
    4. Early diagnosis could make a change in patients' health
    5. Fatigue from least effort is symptom of HCV

    Measured: two years

  3. Percent change using pre and post intervention questionnaire for participants who became motivated and had positive attitude to do something about the problem

    The Attitude:

    1. Asking the barber: to change the shaving tools in front of them
    2. to use their own shaving machine
    3. Checking for sterilized tools at dentist clinic
    4. Telling the dentist if they have/ had HCV

    Measured: two years

  4. Percent change of behavior using pre and post intervention questionnaire for participants who tried out /rejected or adopted the recommended behavior

    The tried out / rejected or adopted : Not sharing:

    1. nail cutters and scissors between family members
    2. loofah and sponge for personal cleaning
    3. the use of scarves' pins by the veiled females in the same family
    4. other's shaving tools
    5. others tooth brushes

    Measured: two tears

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2018
  2. Study start21 May 2015
  3. Primary completion13 May 2017
  4. Study completion21 Oct 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
The study passed through three phases; first phase pre-interventional assessment of level of the recommended behavior development towards eradication of HCV, dominance of current risky behaviors and the wrong believes regarding HCV . The second phase included: community based interventions and the setting of the educational activation plan for HCV elimination in the village and the third was post-intervention evaluation of the change of level of community behaviors adoption according to a preset indicators.
Masking
None (open label)
Enrolment
3,575 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03415334
Sponsor's protocol ID
66187
Status last verified
Jan 2018
First submitted
13 Jan 2018
Last updated
30 Jan 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: After Approval of clinical Trial.gov and having ID

Publications

  • Barrett S. Eradication versus control: the economics of global infectious disease policies. Bull World Health Organ. 2004 Sep;82(9):683-8.

    PubMed 15628206
  • 4) Center for Disease Control (CDC). Division of Viral Hepatitis (DVH) Strategic Plan, 2016-2020: Bringing Together Science and Public-Health Practices for the Elimination of Viral Hepatitis. (2016). http://www.cdc.gov/hepatitis/pdfs/dvh-strategicplan2016-2020-draft.

  • WORLD HEPATITIS SUMMIT HARNESSES GLOBAL MOMENTUM TO ELIMINATE VIRAL HEPATITIS. Cent Eur J Public Health. 2015 Sep;23(3):272. No abstract available.

    PubMed 26618210
  • Heymann DL. Control, elimination, eradication and re-emergence of infectious diseases: getting the message right. Bull World Health Organ. 2006 Feb;84(2):82. doi: 10.2471/blt.05.029512. Epub 2006 Feb 23. No abstract available.

    PubMed 16501719

Questions about this trial

What is this clinical trial studying?

A study testing behavioral development for change in people with Hepatitis C and B VIRUS Screening, Awareness and Behavior Assessment and Evaluation for All Inhabitants Above Twelve Years of Al Othmaneya Village, run by National Research Centre, Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

percent change of awareness using pre and post intervention questionnaire for participants who became aware of the problem (time frame: two years). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03415334, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in